Rapid Health Technology Assessment of Oncotype DX in Patients with Early-Stage Breast Cancer (Review Article)

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

RAHIMI F.; ZEINALIAN M.; Rezayatmand r.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Breast Diseases Year:2022 | Volume:14 | Issue:4 (55) Page(s): 75-93

Download Full-Text

Persian Verion

View:

221

Download:

141

Cites:

Information Journal Paper

Title

Rapid Health Technology Assessment of Oncotype DX in Patients with Early-Stage Breast Cancer (Review Article)

Author(s)

RAHIMI F. | ZEINALIAN M. | Rezayatmand r. | Issue Writer Certificate

Keywords

Breast Cancer

Oncotype DX

Rapid Health Technology Assessmentv

Abstract

Introduction: Breast Cancer is the most common cancer in women. Patients are treated with chemotherapy initially, and if not chemically treated, the risk of recurrence of the disease increases yearly. Therefore, methods for identifying patients for whom chemotherapy would be most beneficial are very important. The Oncotype DX test is a prognostic assay that predicts the likelihood of Breast Cancer recurrence as well as the effectiveness of chemotherapy. Because of the novelty and the high cost of this test, the current study aims to determine its effectiveness and economic effects. Methods: This study, based on rapid health technology assessment, explored the effectiveness and economic consequences of Oncotype DX compared with alternative methods in Breast Cancer patients. PubMed, Scopus, Web of Science, and Cochrane databases were searched, and only studies about the use of the Oncotype DX test in Breast Cancer were included. Results: The results of the 32 relevant studies showed that the difference in outcomes was negligible across Oncotype DX and other gene expression profiling tests, but these differences were significant compared with standard treatment. Also, Oncotype DX testing would be cost-saving when used for patients under chemotherapy. However, using this test for all patients may not be cost-saving depending on the number of patients who switch from hormone therapy to chemotherapy and vice versa. Conclusion: Although the results of this study are helpful for policymakers and therapists, it is better to make decisions based on the results of effectiveness and cost in Iran.

Cites

No record.

References

No record.

Cite

APA: Copy

RAHIMI, F., ZEINALIAN, M., & Rezayatmand, r.. (2022). Rapid Health Technology Assessment of Oncotype DX in Patients with Early-Stage Breast Cancer (Review Article). IRANIAN QUARTERLY JOURNAL OF BREAST DISEASE, 14(4 (55) ), 75-93. SID. https://sid.ir/paper/950253/en

Vancouver: Copy

RAHIMI F., ZEINALIAN M., Rezayatmand r.. Rapid Health Technology Assessment of Oncotype DX in Patients with Early-Stage Breast Cancer (Review Article). IRANIAN QUARTERLY JOURNAL OF BREAST DISEASE[Internet]. 2022;14(4 (55) ):75-93. Available from: https://sid.ir/paper/950253/en

IEEE: Copy

F. RAHIMI, M. ZEINALIAN, and r. Rezayatmand, “Rapid Health Technology Assessment of Oncotype DX in Patients with Early-Stage Breast Cancer (Review Article),” IRANIAN QUARTERLY JOURNAL OF BREAST DISEASE, vol. 14, no. 4 (55) , pp. 75–93, 2022, [Online]. Available: https://sid.ir/paper/950253/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops